• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质中肿瘤组织与宿主组织的代谢底物利用情况

Metabolic substrate utilization by tumour and host tissues in cancer cachexia.

作者信息

Mulligan H D, Tisdale M J

机构信息

Pharmaceutical Sciences Institute, Aston University, Birmingham, U.K.

出版信息

Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):321-6. doi: 10.1042/bj2770321.

DOI:10.1042/bj2770321
PMID:1859359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1151235/
Abstract

Utilization of metabolic substrates in tumour and host tissues was determined in the presence or absence of two colonic tumours, the MAC16, which is capable of inducing cachexia in recipient animals, and the MAC13, which is of the same histological type, but without the effect on host body composition. Glucose utilization by different tissues was determined in vivo by the 2-deoxyglucose tracer technique. Glucose utilization by the MAC13 tumour was significantly higher than by the MAC16 tumour, and in animals bearing tumours of either type the tumour was the second major consumer of glucose after the brain. This extra demand for glucose was accompanied by a marked decrease in glucose utilization by the epididymal fat-pads, testes, colon, spleen, kidney and, in particular, the brain, in tumour-bearing animals irrespective of cachexia. The decrease in glucose consumption by the brain was at least as high as the metabolic demand by the tumour. This suggests that the tissues of tumour-bearing animals adapt to use substrates other than glucose and that alterations in glucose utilization are not responsible for the cachexia. Studies in vitro showed that brain metabolism in the tumour-bearing state was maintained by an increased use of lactate and 3-hydroxybutyrate, accompanied by a 50% increase in 3-oxoacid CoA-transferase. This was supported by studies in vivo which showed an increased metabolism of 3-hydroxybutyrate in tumour-bearing animals. Thus ketone bodies may be utilized as a metabolic fuel during the cancer-bearing state, even though the nutritional conditions mimic the fed state.

摘要

在存在或不存在两种结肠肿瘤的情况下,测定肿瘤和宿主组织中代谢底物的利用情况。这两种肿瘤分别是MAC16,它能够在受体动物中诱导恶病质;以及MAC13,它与MAC16具有相同的组织学类型,但对宿主体成分没有影响。通过2-脱氧葡萄糖示踪技术在体内测定不同组织的葡萄糖利用情况。MAC13肿瘤的葡萄糖利用率显著高于MAC16肿瘤,并且在患有任何一种类型肿瘤的动物中,肿瘤是仅次于大脑的第二大葡萄糖消耗者。对葡萄糖的这种额外需求伴随着附睾脂肪垫、睾丸、结肠、脾脏、肾脏,特别是大脑的葡萄糖利用率显著下降,在患有肿瘤的动物中,无论是否存在恶病质都是如此。大脑葡萄糖消耗的减少至少与肿瘤的代谢需求一样高。这表明患有肿瘤的动物组织适应使用葡萄糖以外的底物,并且葡萄糖利用的改变不是恶病质的原因。体外研究表明,在患有肿瘤的状态下,大脑代谢通过增加乳酸和3-羟基丁酸的利用来维持,同时3-氧代酸辅酶A转移酶增加50%。体内研究支持了这一点,该研究表明患有肿瘤的动物中3-羟基丁酸的代谢增加。因此,即使营养状况模拟进食状态,酮体在患有癌症的状态下也可能被用作代谢燃料。

相似文献

1
Metabolic substrate utilization by tumour and host tissues in cancer cachexia.癌症恶病质中肿瘤组织与宿主组织的代谢底物利用情况
Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):321-6. doi: 10.1042/bj2770321.
2
Lipid metabolism in cancer cachexia.癌症恶病质中的脂质代谢
Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.
3
Metabolic substrate utilization by a tumour cell line which induces cachexia in vivo.一种在体内诱发恶病质的肿瘤细胞系对代谢底物的利用情况。
Br J Cancer. 1986 Oct;54(4):601-6. doi: 10.1038/bjc.1986.215.
4
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.携带结肠腺癌的小鼠肿瘤组织和宿主组织中的脂肪生成
Br J Cancer. 1991 May;63(5):719-22. doi: 10.1038/bjc.1991.162.
5
Reduction of weight loss and tumour size in a cachexia model by a high fat diet.高脂饮食减轻恶病质模型中的体重减轻和肿瘤大小
Br J Cancer. 1987 Jul;56(1):39-43. doi: 10.1038/bjc.1987.149.
6
Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.醋酸甲地孕酮对NMRI小鼠中由肿瘤坏死因子α和一种恶病质诱导肿瘤(MAC16)所致体重减轻的影响。
Br J Cancer. 1990 Sep;62(3):420-4. doi: 10.1038/bjc.1990.310.
7
Catabolic factors in cancer cachexia.癌症恶病质中的分解代谢因素。
In Vivo. 1996 Mar-Apr;10(2):131-6.
8
Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.重组肿瘤坏死因子诱导的体重减轻与恶病质诱导肿瘤所产生的体重减轻的比较。
Br J Cancer. 1988 Apr;57(4):385-9. doi: 10.1038/bjc.1988.87.
9
Tumour-associated hypoglycaemia in a murine cachexia model.小鼠恶病质模型中的肿瘤相关性低血糖症
Br J Cancer. 1992 Nov;66(5):815-20. doi: 10.1038/bjc.1992.366.
10
Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.癌症恶病质小鼠骨骼肌中蛋白酶对caspases-1、-3、-6、-8和-9底物的切割作用。
Br J Cancer. 2001 Apr 20;84(8):1135-40. doi: 10.1054/bjoc.2001.1700.

引用本文的文献

1
Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min/+) model of colon cancer.在Apc(Min/+)结肠癌模型中,膳食脂肪会抵消血小板反应蛋白-1信号传导的保护作用。
Oncogenesis. 2016 May 30;5(5):e230. doi: 10.1038/oncsis.2016.37.
2
Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.VM小鼠转移性癌症的无毒代谢管理:生酮饮食、补充酮体和高压氧治疗的新型组合
PLoS One. 2015 Jun 10;10(6):e0127407. doi: 10.1371/journal.pone.0127407. eCollection 2015.
3
Relating tissue/organ energy expenditure to metabolic fluxes in mouse and human: experimental data integrated with mathematical modeling.将小鼠和人类的组织/器官能量消耗与代谢通量相关联:与数学建模相结合的实验数据
Physiol Rep. 2014 Sep 28;2(9). doi: 10.14814/phy2.12159. Print 2014 Sep 1.
4
Inflammation based regulation of cancer cachexia.基于炎症的癌症恶病质调节。
Biomed Res Int. 2014;2014:168407. doi: 10.1155/2014/168407. Epub 2014 May 4.
5
Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia.癌症恶病质相关厌食症模型中小鼠下丘脑的蛋白质组学分析。
Br J Cancer. 2013 Oct 1;109(7):1867-75. doi: 10.1038/bjc.2013.525. Epub 2013 Sep 3.
6
Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.葡萄糖通过溶酶体依赖性蛋白水解途径调节ras转化的成纤维细胞中的蛋白质分解代谢。
Biochem J. 2001 Jul 1;357(Pt 1):255-61. doi: 10.1042/0264-6021:3570255.
7
Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.恶病质因子对碳水化合物代谢的影响及二十碳五烯酸的减弱作用。
Br J Cancer. 1999 Jun;80(8):1231-5. doi: 10.1038/sj.bjc.6690490.
8
Body protein and lipid deficit in tumour-bearing rats in relation to age.荷瘤大鼠体内蛋白质和脂质缺乏与年龄的关系。
Br J Cancer. 1993 Nov;68(5):885-9. doi: 10.1038/bjc.1993.450.
9
Lipid metabolism in cancer cachexia.癌症恶病质中的脂质代谢
Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.
10
Tumour-associated hypoglycaemia in a murine cachexia model.小鼠恶病质模型中的肿瘤相关性低血糖症
Br J Cancer. 1992 Nov;66(5):815-20. doi: 10.1038/bjc.1992.366.

本文引用的文献

1
Amino acid, glucose, and lactic acid utilization in vivo by rat tumors.大鼠肿瘤在体内对氨基酸、葡萄糖和乳酸的利用情况。
Cancer Res. 1982 Oct;42(10):4090-7.
2
Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells.糖酵解和氧化磷酸化对AS-30D肝癌细胞中三磷酸腺苷生成的贡献。
Cancer Res. 1984 Dec;44(12 Pt 1):5702-6.
3
Brain metabolism during fasting.禁食期间的脑代谢。
J Clin Invest. 1967 Oct;46(10):1589-95. doi: 10.1172/JCI105650.
4
Carbohydrate metabolism in subjects with cancer.癌症患者的碳水化合物代谢
Cancer Res. 1971 Sep;31(9):1273-8.
5
Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues.成年哺乳动物组织中参与乙酰乙酸利用的酶的活性。
Biochem J. 1971 Jan;121(1):41-7. doi: 10.1042/bj1210041.
6
Some biochemical aspects of the relationship between the tumor and the host.
Adv Cancer Res. 1972;15:253-86. doi: 10.1016/s0065-230x(08)60377-2.
7
In vivo lactate production and utilization by Jensen sarcoma and Morris hepatoma 7288CTC.詹森肉瘤和莫里斯肝癌7288CTC在体内的乳酸生成与利用
Cancer Res. 1986 Feb;46(2):689-93.
8
A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat.一种在麻醉大鼠的骨骼肌和白色脂肪组织中定量体内葡萄糖利用的方法。
Biochem J. 1985 May 15;228(1):103-10. doi: 10.1042/bj2280103.
9
Ketone body metabolism in the mother and fetus.母体与胎儿的酮体代谢
Fed Proc. 1985 Apr;44(7):2347-51.
10
Metabolic substrate utilization by a tumour cell line which induces cachexia in vivo.一种在体内诱发恶病质的肿瘤细胞系对代谢底物的利用情况。
Br J Cancer. 1986 Oct;54(4):601-6. doi: 10.1038/bjc.1986.215.